Hikma Pharmaceuticals PLC
HKMPY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,175,766 | $5,516,922 | $5,322,188 | $5,057,253 |
| - Cash | $236,000 | $188,000 | $236,000 | $205,000 |
| + Debt | $1,558,000 | $1,306,000 | $1,276,000 | $1,191,000 |
| Enterprise Value | $7,497,766 | $6,634,922 | $6,362,188 | $6,043,253 |
| Revenue | $1,658,000 | $1,558,000 | $1,569,000 | $1,436,493 |
| % Growth | 6.4% | -0.7% | 9.2% | – |
| Gross Profit | $725,000 | $609,800 | $756,000 | $623,010 |
| % Margin | 43.7% | 39.1% | 48.2% | 43.4% |
| EBITDA | $476,000 | $308,860 | $427,000 | $214,284 |
| % Margin | 28.7% | 19.8% | 27.2% | 14.9% |
| Net Income | $238,000 | $131,661 | $226,000 | $58,531 |
| % Margin | 14.4% | 8.5% | 14.4% | 4.1% |
| EPS Diluted | 2.14 | 1.18 | 2.02 | 0.52 |
| % Growth | 81.4% | -41.6% | 288.5% | – |
| Operating Cash Flow | $161,000 | $319,088 | $198,000 | $342,764 |
| Capital Expenditures | -$68,000 | -$94,339 | -$69,000 | -$95,379 |
| Free Cash Flow | $93,000 | $224,749 | $129,000 | $247,386 |